China, Oct. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical intervention study on the regulation of glucose and lipid metabolism disorders based on gut microbiota modulation.'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135022
Registration Time: 2026/10/23
Type: Interventional study
Primary Sponsor: Shandong First Medical University Affiliated Provincial Hospital (Shandong Provincial Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=292649
Published by HT Digital Content Services with permission from Health Daily Digest....